BRIEF-Amphastar Pharmaceuticals Q4 EPS USD 0.51

Reuters
Feb 27
BRIEF-<a href="https://laohu8.com/S/AMPH">Amphastar Pharmaceuticals</a> Q4 EPS USD 0.51

Feb 26 (Reuters) - Amphastar Pharmaceuticals Q4 adjusted EPS USD 0.73 vs. IBES estimate USD 0.92.

  • Q4 net income USD 24.429 million
  • Q4 adjusted net income USD 34.158 million vs. IBES estimate USD 43.6 million
  • Q4 revenue USD 183.105 million vs. IBES estimate USD 190.5 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10